Voloridge Investment Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Voloridge Investment Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,304	Closed	-$364K	–	1634
2023 Q1	$364K	Buy	+18,304	New	+$316K	﹤0.01%	1265
2022 Q3	–	Sell	-119,780	Closed	-$1.72M	–	1676
2022 Q2	$1.72M	Sell	119,780 -18,239	-13%	-$316K	0.01%	1057
2022 Q1	$3.12M	Buy	138,019 +26,782	+24%	+$520K	0.02%	807
2021 Q4	$2.09M	Buy	+111,237	New	+$2.97M	0.01%	1053
2019 Q2	–	Sell	-19,564	Closed	-$756K	–	1176
2019 Q1	$756K	Buy	+19,564	New	+$663K	0.02%	562

Other funds holding CSII

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Voloridge Investment Management's CSII Position: Q2 2023 in Review

Voloridge Investment Management sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 18,304 shares — an estimated $364K sold.

Voloridge Investment Management first reported a position in CSII in Q1 2019 and held it in 5 quarters. The position peaked at $3.12M in Q1 2022. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

Voloridge Investment Management reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
Voloridge Investment Management sold 18,304 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $364K.
Voloridge Investment Management first reported a position in Cardiovascular Systems, Inc. in Q1 2019 and held it in 5 quarters.
Voloridge Investment Management's Cardiovascular Systems, Inc. position peaked at $3.12M in Q1 2022.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.